Mometasone Furoate Cream — Class III drug recall D-0514-2019
Terminated recall by ACP Nimble Buyer, Inc., reported 2019-02-27, distributed nationwide. Labeling: Not Elsewhere Classified. Mometasone Furoate Cream has an NDC typographical error.
| Recall number | D-0514-2019 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | ACP Nimble Buyer, Inc., South Plainfield, NJ, United States |
| Recall initiated | 2019-02-07 |
| Classified | 2019-02-20 |
| Reported by FDA | 2019-02-27 |
| Terminated | 2020-03-23 |
| Distributed | Nationwide (US) |
| Quantity | 58,176 units |
| Reason classes | labeling |
| NDC | 00713-0726-37 |
| Lot numbers | 1009431, 1009507, 1009886 |
| Expiration dates | 2020-08, 2020-09 |
Product
Mometasone Furoate Cream, 0.1%, 45 g tube, Rx Only, Manufactured by: G&W Laboratories, Inc. South Plainfield, NJ 07080, NDC 0713-0726-37
Reason for recall
Labeling: Not Elsewhere Classified. Mometasone Furoate Cream has an NDC typographical error.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0514-2019. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.